Which are the most common complications related to overstimulation of contractions when using oxytocin?

  1. Blondel B, Coulm B, Bonnet C, Goffinet F, Le Ray C, National Coordination Group of the National Perinatal Surveys. Trends in perinatal health in metropolitan France from 1995 to 2016: results from the French National Perinatal Surveys. J Gynecol Obstet Hum Reprod. 2017;46:701–13. https://doi.org/10.1016/j.jogoh.2017.09.002.

    CAS  Article  PubMed  Google Scholar 

  2. O’Driscoll K, Jackson RJ, Gallagher JT. Prevention of prolonged labour. Br Med J. 1969;2:477–80.

    Article  Google Scholar 

  3. Nachum Z, Garmi G, Kadan Y, Zafran N, Shalev E, Salim R. Comparison between amniotomy, oxytocin or both for augmentation of labor in prolonged latent phase: a randomized controlled trial. Reprod Biol Endocrinol. 2010;8:136. https://doi.org/10.1186/1477-7827-8-136.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Crane JM, Young DC, Butt KD, Bennett KA, Hutchens D. Excessive uterine activity accompanying induced labor. Obstet Gynecol. 2001;97:926–31.

    CAS  PubMed  Google Scholar 

  5. Simpson KR, James DC. Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns. Am J Obstet Gynecol. 2008;199:34.e1–5. https://doi.org/10.1016/j.ajog.2007.12.015.

    CAS  Article  Google Scholar 

  6. Brown HC, Paranjothy S, Dowswell T, Thomas J. Package of care for active management in labour for reducing caesarean section rates in low-risk women. Cochrane Database Syst Rev. 2013:CD004907. https://doi.org/10.1002/14651858.CD004907.pub3.

  7. Glantz JC, McNanley TJ. Active management of labor: a meta-analysis of cesarean delivery rates for dystocia in nulliparas. Obstet Gynecol Surv. 1997;52:497–505.

    CAS  Article  Google Scholar 

  8. Belghiti J, Kayem G, Dupont C, Rudigoz R-C, Bouvier-Colle M-H, Deneux-Tharaux C. Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case-control study. BMJ Open. 2011;1:e000514. https://doi.org/10.1136/bmjopen-2011-000514.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Dupont C, Carayol M, Le Ray C, Deneux-Tharaux C, Riethmuller D, Clinical practice guidelines group. Oxytocin administration during spontaneous labor: guidelines for clinical practice. Guidelines short text. J Gynecol Obstet Hum Reprod. 2017;46:539–43. https://doi.org/10.1016/j.jogoh.2017.04.010.

    CAS  Article  PubMed  Google Scholar 

  10. American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin number 49, December 2003: dystocia and augmentation of labor. Obstet Gynecol. 2003;102:1445–54.

    Google Scholar 

  11. WHO. Recommendations for augmentation of labour. Geneva: World Health Organization; 2014.

    Google Scholar 

  12. Saccone G, Ciardulli A, Baxter JK, Quiñones JN, Diven LC, Pinar B, et al. Discontinuing oxytocin infusion in the active phase of labor: a systematic review and meta-analysis. Obstet Gynecol. 2017;130:1090–6. https://doi.org/10.1097/AOG.0000000000002325.

    CAS  Article  PubMed  Google Scholar 

  13. Daniel-Spiegel E, Weiner Z, Ben-Shlomo I, Shalev E. For how long should oxytocin be continued during induction of labour? BJOG. 2004;111:331–4.

    CAS  Article  Google Scholar 

  14. Bor P, Ledertoug S, Boie S, Knoblauch NO, Stornes I. Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial. BJOG. 2016;123:129–35. https://doi.org/10.1111/1471-0528.13589.

    CAS  Article  PubMed  Google Scholar 

  15. Girard B, Vardon D, Creveuil C, Herlicoviez M, Dreyfus M. Discontinuation of oxytocin in the active phase of labor. Acta Obstet Gynecol Scand. 2009;88:172–7. https://doi.org/10.1080/00016340802649816.

    CAS  Article  PubMed  Google Scholar 

  16. Ustunyurt E, Ugur M, Ustunyurt BO, Iskender TC, Ozkan O, Mollamahmutoglu L. Prospective randomized study of oxytocin discontinuation after the active stage of labor is established. J Obstet Gynaecol Res. 2007;33:799–803. https://doi.org/10.1111/j.1447-0756.2007.00659.x.

    CAS  Article  PubMed  Google Scholar 

  17. Chopra S, SenGupta SK, Jain V, Kumar P. Stopping oxytocin in active labor rather than continuing it until delivery: a viable option for the induction of labor. Oman Med J. 2015;30:320–5. https://doi.org/10.5001/omj.2015.66.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. Diven LC, Rochon ML, Gogle J, Eid S, Smulian JC, Quiñones JN. Oxytocin discontinuation during active labor in women who undergo labor induction. Am J Obstet Gynecol. 2012;207:471.e1–8. https://doi.org/10.1016/j.ajog.2012.08.035.

    CAS  Article  Google Scholar 

  19. Blanc-Petitjean P, Salomé M, Dupont C, Crenn-Hebert C, Gaudineau A, Perrotte F, et al. Labour induction practices in France: a population-based declarative survey in 94 maternity units. J Gynecol Obstet Hum Reprod. 2018;47:57–62. https://doi.org/10.1016/j.jogoh.2017.11.006.

    CAS  Article  PubMed  Google Scholar 


Page 2

  • Policies
  • Accessibility
  • Press center
  • Support and Contact
  • Leave feedback
  • Careers

Follow BMC

  • BMC Twitter page
  • BMC Facebook page
  • BMC Weibo page

Pitocin (oxytocin injection) is a synthetic form of oxytocin. Oxytocin is a hormone that causes the uterus to contract. It is given through an intravenous (IV) line to induce (start) or augment (speed up) contractions during labor. 

This article will discuss Pitocin, including its purpose, risks, and complications.

Ariel Skelley / Getty Images

Pitocin (oxytocin injection) is given intravenously as a method of labor induction, typically at least 39 weeks into pregnancy. You may be given medication first to “ripen” your cervix (the lower part of the uterus) and prepare you for labor. 

If you’ve already gone into labor naturally and aren’t progressing, your healthcare provider may give you Pitocin to speed up your contractions. Usually, Pitocin starts to stimulate contractions within about 30 minutes. 

While Pitocin is being delivered through your IV drip, your medical team will monitor your blood pressure and contractions. They will also monitor your baby for any signs of fetal distress (inadequate oxygen supply).

Estimates suggest that about 22% of pregnant people in the United States have their labor induced, often with a medication like Pitocin.

There are many possible medical reasons for labor induction. Your healthcare provider may recommend Pitocin if:

  • You are more than 42 weeks pregnant and haven’t gone into labor.
  • Your amniotic fluid (the fluid in the sac surrounding the fetus) level is low.
  • Your baby is experiencing intrauterine growth restriction (IUGR) and isn’t growing fast enough.
  • You have chorioamnionitis (an infection of the amniotic fluid and placenta—the organ that develops in the uterus to provide blood and nutrients to the developing fetus).
  • You have premature rupture of membranes (PROM), meaning that your amniotic sac ruptured on its own but you aren’t having contractions.
  • You have gestational diabetes.
  • You have high blood pressure.
  • There are problems with your heart, kidneys, or other major organs.
  • There are problems with the function or size of the placenta.

Pitocin may be administered on its own to induce or speed up labor contractions. Injectable oxytocin may also be used alongside other methods of labor induction, such as rupturing the amniotic sac (the sac that contains amniotic fluid and protects the fetus during pregnancy).

When used for medical reasons, Pitocin is typically safe and effective for both the pregnant person and fetus. Side effects of Pitocin may include:

  • Nausea
  • Vomiting
  • Fever during childbirth

In some cases, Pitocin may slow down contractions or cause them to be irregular. This can increase your risk of needing an emergency cesarean delivery (C-section) if your body is not ready. A C-section is the surgical delivery of the baby. The possible risks of a C-section include:

  • Blood loss
  • Blood clots
  • Infection
  • Bladder or bowel injuries 

If your labor is induced and your due date wasn’t calculated correctly, you may have an increased risk of giving birth to a late preterm baby. A late preterm baby (born between 34 and 37 weeks) could have certain health and behavioral concerns, such as:

  • Jaundice (yellowing of the skin caused by excess bilirubin in the blood)
  • Breathing problems
  • Difficulty maintaining body temperature 
  • Problems with breastfeeding
  • Developmental delays in early childhood

Because of the possible risks of an elective induction (an induction of labor for convenience or personal preference), you should ideally be given Pitocin only if it is medically necessary.

In certain cases, it may not be safe to induce labor with Pitocin. Your healthcare provider may recommend that you have a C-section instead if certain conditions are present, such as:

  • Breech presentation (when the baby is positioned head up instead of head down)
  • Placenta previa (when the placenta partially or completely covers the cervix)
  • Infection, such as genital herpes
  • Umbilical cord prolapse (when the umbilical cord drops into the birth canal before the baby)
  • Cervical cancer
  • A history of uterine surgery or prior C-sections

While rare, some serious medical complications are possible when using Pitocin to induce labor. Severe complications from Pitocin may include:

  • Uterine rupture (tearing of the uterus)
  • Uterine hyperstimulation, which can cause contractions that are too long, frequent, or severe
  • Seizures (uncontrolled electrical activity in the brain) caused by low blood pressure or low sodium levels
  • Excessive bleeding
  • Symptoms of a severe allergic reaction, such as rash, hives, difficulty breathing, rapid heartbeat, or swelling

In very rare cases, Pitocin may cause fetal distress, fetal health complications, or stillbirth.

If you experience any side effects from Pitocin, let your healthcare provider know right away. They can decrease your dose or give you other medications to help to control your symptoms. 

Pitocin (oxytocin injection) is a synthetic form of oxytocin—a hormone that stimulates the uterus. It is given intravenously to start or speed up labor contractions during childbirth. 

Your healthcare provider may recommend using Pitocin to induce labor if you are more than 42 weeks pregnant or if your amniotic sac has already ruptured but your contractions haven’t started.

They may also recommend Pitocin due to certain medical conditions, such as a uterine infection, gestational diabetes, high blood pressure, restricted fetal growth, problems with the placenta, or problems with your major organs. 

Side effects from Pitocin may include nausea, vomiting, and fever. In some cases, Pitocin may slow down or prolong labor, increasing the risk of an emergency C-section. Serious complications from Pitocin, such as uterine rupture or excessive bleeding, are rare.

When medically necessary, Pitocin can be a safe, effective way to induce labor. If you’re concerned about the potential side effects of Pitocin, talk to your healthcare provider as early as possible in your pregnancy.

Thanks for your feedback!

What are your concerns?

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

  1. MedlinePlus. Oxytocin injection.

  2. Johns Hopkins Medicine. Labor.

  3. MedlinePlus. Inducing labor.

  4. American College of Obstetricians and Gynecologists. Labor induction.

  5. Nemours KidsHealth. Inducing labor.

  6. Daly D, Minnie KCS, Blignaut A, et al. How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries. PLoS One. 2020;15(7):e0227941. doi:10.1371/journal.pone.0227941

  7. Johns Hopkins Medicine. Anatomy: fetus in utero.

  8. Hidalgo-Lopezosa P, Hidalgo-Maestre M, Rodríguez-Borrego MA. Labor stimulation with oxytocin: effects on obstetrical and neonatal outcomes. Rev Lat Am Enfermagem. 2016;24:e2744. doi:10.1590/1518-8345.0765.2744

  9. The American College of Obstetricians and Gynecologists. Cesarean birth.

  10. Cheong JL, Doyle LW, Burnett AC, et al. Association between moderate and late preterm birth and neurodevelopment and social-emotional development at age 2 years. JAMA Pediatr. 2017;171(4):e164805. doi:10.1001/jamapediatrics.2016.4805

  11. Brahmawar Mohan S, Sommerfelt H, Frøen JF, et al. Antenatal uterotonics as a risk factor for intrapartum stillbirth and first-day death in Haryana, India: a nested case-control study. Epidemiology. 2020;31(5):668-676. doi:10.1097/EDE.0000000000001224

What are the complications of oxytocin?

Side Effects.
Confusion..
convulsions (seizures).
difficulty in breathing..
fast or irregular heartbeat..
headache (continuing or severe).
hives..
pelvic or abdominal pain (severe).
skin rash or itching..

What is the main complication of oxytocin administration?

excessive bleeding long after childbirth; severe headache, blurred vision, pounding in your neck or ears; or. confusion, severe weakness, feeling unsteady.

What happens when uterus is overstimulated by oxytocin?

If overstimulation of the uterus occurs, not only can this adversely affect fetal oxygen exchange through the placenta, but uterine rupture can occur. Following delivery of the baby and placenta, oxytocin is commonly given in moderate doses to control uterine bleeding.

Does oxytocin cause hyperstimulation?

Every obstetrician knows that oxytocin administration during labour can cause uterine hyperstimulation (tachysystole) and fetal heart rate abnormalities.